Myocardial Solutions (MSI) has hired Rafael Rivero, MD as Global Head of Medical Affairs. Rafael’s focus is on expanding utilization and advocacy of MSI’s cardiac diagnostic software, MyoStrain®, in the medical community. Rafael brings over 17 years of experience leading and transforming both...
Myocardial Solutions’ MyoStrain was featured in two different abstracts that were presented at the American College of Cardiology’s 68th Annual Scientific Session & Expo. The event was held in New Orleans, Louisiana on March 16th – 18th, 2019.One abstract was based on a study completed at Sharon...
After its initial closing of $6.6 million in December, Myocardial Solutions, Inc. has rounded out and completed its’ Series C financing round of $7.0 million of equity investment. The funding round was led by a family office. The company has now raised a total of $16.0 million since it was...
Myocardial Solutions’ MyoStrain® was featured in two different abstracts that were presented at the 11th annual German Cardiac Diagnostics Days (DKDT) symposium 2019. The event was held in Leipzig, Germany on February 21st-23rd, 2019. Both abstracts were based on studies at Heidelberg University...
Myocardial Solutions, Inc. (MSI) announced FDA 510(k) clearance for MSI’s MyoStrain diagnostic software, providing a new, rapid, accurate, and safe segmental strain test for quantifying subclinical cardiac dysfunction. MyoStrain quantifies cardiac contraction across 48 segments of the heart in a...
